MonoHER selectively enhances the radiotherapy response in p53 wild-type breast cancer via stabilization of p53

MonoHER modestly sensitize only p53-proficient breast cancer cells to radiation by stabilizing and activating p53, highlighting its potential as an adjuvant radiosensitizer.